Bayer Plans $2.2 Billion Integrated Drug Plant in New Albany, Ohio
Bayer will invest $2.2 billion in a new pharmaceutical campus in New Albany, Ohio, that puts drug substance and drug product manufacturing on one site, with heavy use of digital and automation systems. Construction is expected to start in 2027, and manufacturing is scheduled to begin in 2031.
Our summary of an article from 10TV (WBNS Columbus). Read the original at 10TV (WBNS Columbus)
What It Means
A greenfield campus that handles both drug substance and drug product sets up a long chain of linked work: process design, facility and utility builds, automation, and a qualification program that has to cover two kinds of manufacturing on one site. With ground broken in 2027 and output starting in 2031, the early design and validation planning will decide how smoothly the later phases go. It is also another sign that big drug companies are making long-term bets on U.S. production.
Read the original at 10TV (WBNS Columbus).
